<html>
  <head></head>
  <body>
    <div id="title">
      <h2>"Point in Time" Regulation Content</h2>
      <h4>
        <em> Pharmacy Operations and Drug Scheduling Act </em>
      </h4>
      <h3 style="line-height: 110%">Drug Schedules Regulation</h3>
      <h3>B.C. Reg. 9/98</h3>
    </div>
    <table
      align="center"
      border="0"
      cellpadding="3"
      cellspacing="0"
      class="tablestyle1"
    >
      <tbody
        xmlns:act="http://www.gov.bc.ca/2013/legislation/act"
        xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table"
        xmlns:xlink="http://www.w3.org/1999/xlink"
      >
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Acetylcysteine</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Allethrins (pyrethrins)</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Alverine and its salts (for parenteral use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Amino acid solutions (for parenteral use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Arginine and its salts</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Artemisia, its preparations, extracts and compounds (except in trace
            amounts in homeopathic preparations)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Belladonna alkaloids, and their salts and derivatives (except in
            preparations for topical use or in trace amounts in homeopathic
            preparations)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Benzocaine and its salts (for parenteral or ophthalmic use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Benzyl benzoate</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Bisacodyl and its salts except when sold in
            <br />
            (a) concentrations of 5 mg or less per oral dosage unit or 10 mg or
            less per rectal dosage unit/suppository, and
            <br />
            (b) package sizes containing no more than 50 mg of bisacodyl
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Boric acid and its salts (in preparations for systemic use, or
            ophthalmic preparations in concentrations of greater than 2%) [Note:
            does not apply to contact lens solutions intended to be rinsed off
            prior to placement of lens on the eye]
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Camphor (in oleaginous vehicles and in liquid forms in
            concentrations greater than 11%)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Cantharides, their preparations and derivatives
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Choline bitartrate (parenteral)</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Chymopapain (parenteral)</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Chymotrypsin (parenteral and ophthalmic)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Dextrose (sclerosing agents)</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Epinephrine and its salts (other than in pre-filled syringes
            intended for emergency administration by injection in the event of
            anaphylactic reactions to allergens)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Esdepallethrin/piperonyl butoxide</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Heparin and its salts (except for topical use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Histamine and its salts (except for topical use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Hyaluronic acid and its salts (preparations in concentrations of 5%
            or more)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Hyaluronidase</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Hydrocortisone or hydrocortisone acetate
            <a href="#footnote_V">
              <sup> V </sup>
            </a>
            (except when sold in a concentration that provides 1% or less
            hydrocortisone in preparations for topical use on the skin, for
            adults and children 2 years of age and over, and in package sizes
            containing no more than 30 g)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Hydroquinone or its derivatives, when sold in a concentration
            greater than 2% in preparations for topical use on the skin
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Hydroquinone or its derivatives, when sold in a concentration less
            than or equal to 2% in preparations for topical use on the skin
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Hyoscine and its salts and derivatives [scopolamine] (except
            hyoscine butylbromide, when recommended for parenteral use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Hyoscyamine and its salts and derivatives (except for topical use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Iodine and its salts and derivatives (except topical preparations or
            in oral doses of 1 mg or less per day)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Ipecac and its extracts and derivatives (when used as an emetic)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Iron and its salts and derivatives (preparations with more than
            30 mg elemental iron per solid dosage unit or 5 mL oral liquid)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Lobelia and its alkaloids and preparations (except internal
            preparations containing not more than 2 mg lobeline sulphate,
            external preparations containing not more than the equivalent of 400
            mg of crude lobelia or preparations containing 130 mg or less of
            lobelia inflata)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Magnesium sulfate (for parenteral use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Mannitol and its salts</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Methenamine and its salts (except for topical use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Methyl salicylate (in liquid dosage forms in concentrations greater
            than 30%)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Nicotinic acid [niacin] in extended-release formulations, except
            when sold in a modified-release oral dosage form that provides 500
            mg or more per dosage unit or per daily dose
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">Nicotinyl-tartrate</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Norepinephrine and its salts (levarterenol, noradrenaline)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Phenol (preparations with concentration of more than 20%)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Physostigmine salicylate (for oral or topical use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Potassium salts (in oral preparations containing more than 5 mmol
            per single dose, except
            <br />
            (a) potassium bromide,
            <br />
            (b) potassium gluconate when sold or recommended for administration
            to cats,
            <br />
            (c) potassium para-aminobenzoate, and
            <br />
            (d) potassium citrate when recommended for the treatment of renal
            tubular acidosis and kidney stones)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Povidone - iodine (vaginal preparations, except in concentrations of
            5% or less)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Pyrethrins (allethrins)</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Pyrethrins (allethrins) /piperonyl butoxide
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">Quinidine salts</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">Quinine salts</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Racemethionine</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Rue and its preparations and extracts
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Salicylic acid (when sold to be applied to warts, corns or calluses
            in topical preparations in concentrations greater than 40%)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Scopolamine and its salts (hyoscine)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Silver nitrate</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Sodium acetate (for parenteral use)</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Sodium biphosphate (for parenteral use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Sodium chloride (single ingredient solutions for parenteral or
            ophthalmic use in concentrations of more than 0.9%) [NOTE: Does not
            apply to contact lens solutions intended to be rinsed off prior to
            insertion into eye]
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Sodium citrate (for parenteral use)</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Sodium iodide (for sclerosing)</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Sodium phosphate (for parenteral use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Stramonium and its preparations, extracts, and compounds
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Strontium and its salts (for parenteral use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Vitamins (any parenterals not otherwise scheduled in Schedule I)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Xylose</td>
        </tr>
      </tbody>
    </table>
  </body>
</html>
